Neidhart, Jeffrey

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor. [electronic resource] - Vaccine Jan 2004 - 773-80 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0264-410X

10.1016/j.vaccine.2003.08.021 doi


Adjuvants, Immunologic--pharmacology
Adult
Aged
Antibodies, Neoplasm--analysis
Antibody Formation--immunology
Antigen-Antibody Reactions
Antigens, Neoplasm--immunology
Baculoviridae--immunology
Cancer Vaccines--adverse effects
Cell Adhesion Molecules--immunology
Cell Division
Chemistry, Pharmaceutical
Colorectal Neoplasms--immunology
Emulsions
Enzyme-Linked Immunosorbent Assay
Epithelial Cell Adhesion Molecule
Escherichia coli--immunology
Female
Granulocyte Colony-Stimulating Factor--pharmacology
Humans
Immunity, Cellular--immunology
Immunization
Interferon-gamma--biosynthesis
Lipid A--chemistry
Liposomes
Lymphocyte Count
Male
Middle Aged
Mineral Oil
Pilot Projects
Recombinant Proteins
Skin Tests
Vaccines, Synthetic--immunology